StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $0.72 | $0.72 | +0.58% | 0.1M |
| 05-15 | $0.75 | $0.71 | -5.56% | 0.0M |
| 05-18 | $0.71 | $0.69 | -3.01% | 0.1M |
| 05-19 | $0.71 | $0.70 | -1.41% | 0.0M |
| 05-20 | $0.69 | $0.71 | +2.29% | 0.0M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.38M | $3.94M | $2.46M | $1.29M |
Operating Income | $-3.28M | $-12.79M | $-9.93M | $-6.53M |
Net Income | $-3.48M | $-12.56M | $-9.72M | $-6.38M |
EPS (Diluted) | $0.31 | $-1.70 | $-1.48 | $-1.14 |
Total Assets | $12.84M | $10.76M | $10.37M | $11.11M |
Total Liabilities | $10.94M | $5.72M | $5.57M | $4.40M |
Cash & Equivalents | $4.61M | $3.76M | $3.44M | $7.85M |
Free Cash Flow OCF − CapEx | $-3.02M | $-11.02M | $-8.60M | $-4.89M |
Shares Outstanding | 11.30M | 10.85M | 8.61M | 7.59M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.